Screener
Arcutis Biotherapeutics, Inc. ARQT Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Amortizedcost | Unrealizedgains | Unrealizedlosses | Estimatedfair value |
|---|---|---|---|---|
| Money market funds and cash | $28,658 | — | — | $28,658 |
| Certificates of deposit | 5,463 | — | — | 5,463 |
| Total cash and cash equivalents | $34,121 | — | — | $34,121 |
| Marketable securities: | ||||
| Commercial paper | $16,584 | — | $(17) | $16,567 |
| Corporate debt securities | 94,325 | 1 | (192) | 94,134 |
| U.S. Treasury and agency securities | 93,856 | — | (126) | 93,730 |
| Total marketable securities | $204,765 | $1 | $(335) | $204,431 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax)?
- Arcutis Biotherapeutics, Inc. (ARQT) reported unrealized losses on investments (before tax) of $335K in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax) changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax) increased by 11066.7% year-over-year, from $3K to $335K.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax)?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax) has grown at a 18.5% compound annual growth rate (CAGR), from $9K to $21K.
- What does unrealized losses on investments (before tax) mean?
- The total unrealized losses on investments, typically related to available-for-sale securities, before considering tax effects.
Ask your AI about Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude